Get started
Author

Michel Flesch

Observed names: F. Michel, M FLESCH, M Flesch, M. FLESCH, M. Flesch, MICHEL FLESCH
Observed institutions: American Society of Clinical Oncology, Netherlands Organisation for Applied Scientific Research, Inserm, University of Münster, Hôpital Beaujon, Tel Aviv Sourasky Medical Center, Centre Hospitalier Universitaire de Grenoble, Karolinska Institutet, Sanofi (France), Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire Henri-Mondor, Centre Hospitalier Universitaire de Besançon, Institute Mutualiste Montsouris, Hospital Clínico Universitario de Valencia, Centre Georges François Leclerc, Assistance Publique – Hôpitaux de Paris, European Society for Blood and Marrow Transplantation, Marqués de Valdecilla University Hospital, International Drug Development Institute (Belgium), Clinique Saint Jean, Hôpital Saint-Antoine, Centre Hospitalier Universitaire de Reims, Centre Eugène Marquis, Centre Hospitalier de Beauvais, CHU Dijon Bourgogne, Hôpital Clinique Claude-Bernard, Centre Hospitalier Universitaire de Limoges, Pitié-Salpêtrière Hospital, Centre François Baclesse, Hôpital Edouard Herriot, GERCOR (France), Intergroupe Francophone du Myélome, Hôpital Privé Jean Mermo, Hôpitaux Universitaires Henri-Mondor, Centre de Recherche Saint-Antoine, Clinique Victor Hugo, Hôpital Saint-Jacques, Hôpital Foch, International Drug Development, Institut Sainte Catherine, Hospital Xeral Calde, European Society for Blood and Marrow Transplantation, Hôpital Tenon, Hasselt University
OpenAlex ID: A5043616696
OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study
2006 · Christophe Tournigand, Andres Cervantes, et al. · Journal of Clinical Oncology · 808
Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study
2009 · Benoist Chibaudel, Frédérique Maindrault-Goebel, et al. · Journal of Clinical Oncology · 392
Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial
2003 · Thierry André, Philippe Colin, et al. · Journal of Clinical Oncology · 261
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992 · P Herve, M Flesch, et al. · Blood · 179
Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1
2007 · Thierry André, Emmanuel Quinaux, et al. · Journal of Clinical Oncology · 153
Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer
2007 · Aimery de Gramont, Marc Buyse, et al. · Journal of Clinical Oncology · 133
Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double- blind placebo-controlled trial
1992 · NC Gorin, B Coiffier, et al. · Blood · 105
PDF
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients
2009 · Marie‐Christine Etienne‐Grimaldi, Gérard Milano, et al. · British Journal of Clinical Pharmacology · 103
PDF
Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)
2010 · M. Maynadie, F. Girodon, et al. · Haematologica · 96
PDF
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer
2007 · Arié Figer, Nathalie Perez‐Staub, et al. · Cancer · 86
PDF
Melphalan-Prednisone-Thalidomide (MP-T) Demonstrates a Significant Survival Advantage in Elderly Patients ≥75 Years with Multiple Myeloma Compared with Melphalan-Prednisone (MP) in a Randomized, Double-Blind, Placebo-Controlled Trial, IFM 01/01.
2007 · Cyrille Hulin, Thierry Facon, et al. · Blood · 67
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation
1987 · G Gahrton, S Tura, et al. · Blood · 64
PDF
OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer
2004 · A. De Gramont, A. Cervantes, et al. · Journal of Clinical Oncology · 55
A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients
2006 · on behalf of GERCOR, M Mabro, et al. · British Journal of Cancer · 48
PDF
Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
2006 · Jean-François Abgrall, Isabelle Guibaud, et al. · PubMed · 47
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study
2006 · T. André, C. Tournigand, et al. · Annals of Oncology · 44
PDF
Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement
1987 · P Herve, JY Cahn, et al. · Blood · 44
PDF
[Adjuvant treatment of colon cancer MOSAIC study's main results].
2006 · Thierry André, Christophe Tournigand, et al. · PubMed · 43
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
2001 · C. Louvet, T. André, et al. · Annals of Oncology · 42
Removal of Marrow T Cells With Okt3-okt11 Monoclonal Antibodies and Complement to Prevent Acute Graft-versus-host Disease
1985 · P. HERVE, M. FLESCH, et al. · Transplantation · 40
Autologous bone marrow transplantation (ABMT) for acute leukaemia in complete remission: a pilot study of 33 cases
1986 · J. Y. Cahn, P. Herve, et al. · British Journal of Haematology · 38
Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.
1993 · L Sutton, M Kuentz, et al. · PubMed · 37
High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries.
2006 · Laurence Faivre, Jörg Meerpohl, et al. · PubMed · 33
Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide)
1984 · P. Hervé, J. Y. Cahn, et al. · Investigational New Drugs · 28
Phase II Trial Alternating FOLFOX-6 and FOLFIRI Regimens in Second-Line Therapy of Patients with Metastatic Colorectal Cancer (FIREFOX Study)
2006 · Mohamed Hebbar, Christophe Tournigand, et al. · Cancer Investigation · 24
Works count: 106
Citation count: 3,469
H-index: 24
I10-index: 50
Year
Topic
Type